Loading...
Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
Mutations in the epidermal growth factor receptor (EGFR) gene are the most common targetable genomic drivers of non-small cell lung cancer (NSCLC), occurring in approximately 50% and 10–15% of adenocarcinomas of the lung in Asian and Western populations, respectively. The most common EGFR-activating...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894985/ https://ncbi.nlm.nih.gov/pubmed/31857949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.06.01 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|